Above products are not available in patent covered areas, or only used for laboratory research and development.
*The following content is generated by AI and is for reference only.
<h3>Overview</h3>
<p>Delafloxacin meglumine is a broad-spectrum <strong>fluoroquinolone antibiotic</strong>. It combines delafloxacin with meglumine to enhance water solubility for parenteral administration. The molecular formula is C<sub>22</sub>H<sub>26</sub>F<sub>2</sub>N<sub>4</sub>O<sub>7</sub> and CAS number is 1590786-36-1.</p>
<h3>Application</h3>
<ul>
<li><strong>Infectious Disease Management:</strong> Treatment of acute bacterial skin and skin structure infections (ABSSSI).</li>
<li><strong>Respiratory Infections:</strong> Indicated for community-acquired bacterial pneumonia (CABP).</li>
<li><strong>IV Formulation:</strong> Used in hospital settings requiring rapid systemic absorption.</li>
</ul>
<h3>Precautions</h3>
<p>Contraindicated in patients with hypersensitivity to fluoroquinolones. Monitor for tendonitis, QT prolongation, and peripheral neuropathy. Store vials at controlled room temperature away from direct light.</p>